Results 261 to 270 of about 10,026 (288)

Gastric Retention of Enteric-Coated Magnesium Chloride Tablets

Annals of Pharmacotherapy, 1994
OBJECTIVE: To describe a patient with gastric retention of enteric-coated magnesium chloride tablets. Potential drug and disease etiologies accounting for failure to empty this dosage form are discussed. DESIGN: Single case report. CASE SUMMARY: A seriously ill patient with metastatic small-cell lung cancer accumulated 21 enteric-coated magnesium ...
Lisa B. Korman, Dennis J. Chapron, William L. Barry   +2 more
openaire   +2 more sources

Absorption and Metabolism of Aspirin Administered in Enteric-Coated Tablets

JAMA: The Journal of the American Medical Association, 1965
Variations in the absorption pattern of aspirin in enteric-coated tablets and in solution were compared between subjects and between doses in any one subject. Absorption of enteric-coated tablets was complete but the rate was extremely variable. On the other hand, administration of aspirin in solution was not only complete, but also yielded well ...
Jack R. Leonards, Gerhard Levy
openaire   +3 more sources

Crushed Enteric-Coated Methenamine Tablets

JAMA: The Journal of the American Medical Association, 1973
To the Editor.— The authors of the article, "Lipoid Pneumonia Caused By Methenamine Mandelate Suspension" (225:1524, 1973), concluded that "Simply, methenamine tablets can be crushed and given with food to problem patients." Methenamine mandelate (Mandelamine) is available as an entericcoated tablet (0.25, 0.5, 1.0 gm).
openaire   +2 more sources

Dissolution Behavior of Commercial Enteric-coated Aspirin Tablets

Journal of Pharmaceutical Sciences, 1979
Dissolution behavior was studied for four commercial batches of enteric-coated aspirin tablets from two companies. The USP XIX dissolution procedure was modified by including pretreatment in simulated gastric juice. The effects of five pretreatment times were studied.
Koral Embil, George Torosian
openaire   +3 more sources

Tableting and stability evaluation of enteric-coated omeprazole pellets

European Journal of Pharmaceutics and Biopharmaceutics, 2004
In this study, fluidized-bed manufactured enteric-coated omeprazole pellets were compressed into tablets. The stability of the pellets and those of compressed tablets were evaluated for remaining omeprazole and for degradation products under an accelerated stability protocol. The data were analyzed using the artificial neural network (ANN) and analysis
Murat Türkoğlu, Mine Çelikok, Hakan Varol   +2 more
openaire   +3 more sources

Gastric retention of enteric‐coated aspirin tablets in beagle dogs

Journal of Veterinary Pharmacology and Therapeutics, 1990
Nap, R.C., Breen, D.J., Lam, T.J.G.M. & de Bruyne, J.J. Gastric retention of enteric‐coated aspirin tablets in beagle dogs. J. vet. Pharmacol. Therap. 13, 148–153.Administration of acetylsalicyclic acid (ASA) in the dog may cause gastric mucosal damage. Enteric‐coated tablets protect the canine stomach during oral ASA medication.
D.J. Breen, Theo J.G.M. Lam, J J de Bruyne, R. C. Nap   +3 more
openaire   +4 more sources

Eosinophilic gastroenteritis treated with non-enteric-coated budesonide tablets

European Journal of Gastroenterology & Hepatology, 2001
A patient who presented with upper abdominal pain, nausea and ascites together with peripheral eosinophilia is described. Based on a surgical full-thickness biopsy of the antrum, the diagnosis of eosinophilic gastroenteritis was made. Treatment with prednisone resulted in a clinical response, but the prednisone dose could not be lowered below 5 mg.
Tan, A., Kruimel, J.W., Naber, A.H.J.
openaire   +4 more sources

Aspirin—A National Survey V: Determination of Aspirin and Impurities in Enteric Coated Tablets and Suppository Formulations and In Vitro Dissolution of Enteric Coated Tablets

Journal of Pharmaceutical Sciences, 1982
The results of a national survey on the quality of enteric coated aspirin tablets and aspirin suppositories are presented. The tablets were analyzed for strength, salicylic acid content, in vitro dissolution rate, and related aspirin impurities. The suppositories were analyzed for strength and salicylic acid content.
Paul E. Flinn, Ross D. Kirchhoefer, Everett H. Jefferson   +2 more
openaire   +3 more sources

Formulation and Development of Enteric Coated Tablet for Parkinson's Disease

Research Journal of Pharmacy and Technology, 2020
The current investigation is to formulate and develop enteric coated tablet of Ropinirole Hydrochloride. Enteric coated tablets were prepared by Wet Granulation method by using water as solvent. To protect drug from acid Eudragit L-100 was used as enteric coated polymer.
Rutuja R F, Rajkumar V. Shete, Ravindra A Dhawale, Rahul S. Solunke, K J Kore, Madhuri T. Deshmukh   +5 more
openaire   +2 more sources

Tolerance of Didanosine as Enteric-Coated Capsules versus Buffered Tablets

AIDS Patient Care and STDs, 2004
329 E Didanosine (ddI) is a nucleoside analogue that competitively inhibits the HIV reverse transcriptase enzyme. The lability of the molecule in acid milieu reduces its bioavailability to 10% when administered orally.1 A first approach to overcome this limitation was the formulation of ddI as buffered tablets, so that the absorption of the drug was ...
Pablo Barreiro, Vincent Soriano, Marina Núñez, Arturo Corbatón, Juan González-Lahoz   +4 more
openaire   +3 more sources